Aerie Pharmaceuticals (NASDAQ: AERI)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Aerie Pharmaceuticals (NASDAQ: AERI) through any online brokerage.
The latest price target for Aerie Pharmaceuticals (NASDAQ: AERI) was reported by HC Wainwright & Co. on Monday, May 9, 2022. The analyst firm set a price target for 20.00 expecting AERI to rise to within 12 months (a possible 124.47% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Aerie Pharmaceuticals (NASDAQ: AERI) is $8.91 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aerie Pharmaceuticals.
Aerie Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Aerie Pharmaceuticals.
Aerie Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.